Skin News and Research

RSS

New CDC push to teach parents how to protect children from MRSA

The Centers for Disease Control and Prevention (CDC) today launched a national campaign to teach parents how to keep their children safe from skin infections caused by the potentially dangerous bacteria Methicillin-resistant Staphylococcus aureus (MRSA).

8 Sep 2008

Egg secretions from a worm may be useful in gene therapy

Egg secretions from a worm that causes a deadly human disease may prove useful in gene therapy, according to research presented at the British Pharmaceutical Conference (BPC) in Manchester.

8 Sep 2008

Healthy individuals may be at risk for heart disease

In the face of a growing obesity epidemic in the United States, researchers at Wake Forest University Baptist Medical Center have new study results that indicate that how much fat a person has is not as important as where that fat is located when assessing risk for cardiovascular events and metabolic disease.

8 Sep 2008

How fat, less important than where that fat is!

The latest research from the U.S. says how fat a person is may be less important than where that fat is.

8 Sep 2008

Light-activated drug used to tackle MRSA

New treatment using a light-activated drug could revolutionise the fight against hospital "superbug", MRSA (otherwise known as Meticillin resistant staphylococcus aureus) it was revealed at the British Pharmaceutical Conference (BPC) in Manchester.

7 Sep 2008

Natural birth better for bonding baby and mother

American researchers are suggesting that natural birth may make mothers more responsive to their babies than those who choose to have a Caesarean.

4 Sep 2008

MRSA breast infections controllable in nursing mothers, researchers find

Many nursing mothers who have been hospitalized for breast abscesses are afflicted with the "superbug" methicillin-resistant Staphylococcus aureus, or MRSA, but according to new research by UT Southwestern Medical Center physicians, conservative treatment can deal with the problem.

3 Sep 2008

Further analysis from ATHENA study showed Multaq (Dronedarone) reduced risk of stroke in patients with atrial fibrillation

The results of a post-hoc analysis of the data from the ATHENA study were presented today at the clinical trial update session of the European Society of Cardiology congress 2008, in Munich, Germany.

3 Sep 2008

New guidelines for dealing with earwax

Ear Nose and Throat (ENT) specialists in the U.S. have come up with new guidelines for dealing with earwax.

2 Sep 2008

Most vaccine-allergic children can still be safely vaccinated

With close monitoring and a few standard precautions, nearly all children with known or suspected vaccine allergies can be safely immunized, according to a team of vaccine safety experts led by the Johns Hopkins Children's Center. Writing in the September issue of Pediatrics, the multicenter research team offers pediatricians a step-by-step tool for quickly identifying children with allergic reactions to vaccines, and a much-needed guide, they say, to safely immunize those who are allergic.

2 Sep 2008

MorphoSys announces publication of first MOR103 data

MorphoSys AG announced today the publication of a first data package for its most advanced proprietary drug development program MOR103, a fully human HuCAL antibody directed against GM-CSF, in the journal "Molecular Immunology".

2 Sep 2008

Earwax removal - new guidelines

The American Academy of Otolaryngology - Head and Neck Surgery Foundation (AAO-HNSF) will issue the first comprehensive clinical guidelines to help health care practitioners identify patients with cerumen (commonly referred to as earwax) impaction. The guidelines emphasize evidence-based management of cerumen impaction by clinicians, and inform patients of the purpose of ear wax in hearing health.

1 Sep 2008

Pregnant women warned off using perfumed products

Pregnant women have been warned not to use scented creams or perfumes during the first three months of their pregnancy because they may jeopardise the future fertility of unborn boys.

1 Sep 2008

Impact of school based programs for childhood overweight

Childhood overweight and obesity are serious, large-scale, global, public health concerns and the number of children affected is still increasing every year. As the treatment of overweight and obesity is rarely effective, its prevention has priority today.

1 Sep 2008

New genetic link to inflammatory bowel diseases discovered

A study which entailed scientists trawling through the genetic code of thousands of people, has revealed two new genes involved in childhood inflammatory bowel disease, a painful condition that includes Crohn's disease and ulcerative colitis (UC).

1 Sep 2008

Transformation of ordinary cells into insulin-makers improves symptoms of diabetes

Scientists in the U.S. have successfully transformed ordinary cells into insulin-producing cells in a living mouse and thereby improved the symptoms of diabetes.

28 Aug 2008

Exclusive breastfeeding increases child's risk for vitamin D deficiency; black, darker-skinned children already have increased risk

Exclusive breastfeeding can increase a child's risk of developing rickets because breast milk alone does not provide adequate levels of vitamin D, a critical ingredient that helps to absorb calcium and build strong bones, the New York Times reports. Rickets develops when a child's vitamin D levels are too low and is characterized by the curving of a child's legs and the softening of other bones. Some children are asymptomatic.

28 Aug 2008

VioQuest Pharmaceuticals issued new U.S. patent for Lenocta

VioQuest Pharmaceuticals today announced that the United States Patent and Trademark Office has issued the first patent for the company's investigational product candidate Lenocta (sodium stibogluconate). U.S. Patent No. 7,416,723 entitled "Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases," encompasses novel compositions including Lenocta for the treatment of cancer and a broad range of other diseases.

26 Aug 2008

HIV/AIDS groups express concern about potential for new antiretroviral advertising to 'scare off' patients

The Wall Street Journal on Monday examined a new trend for drugmakers marketing HIV/AIDS treatments to release ads that "tak[e] aim at rival HIV drugs, hinting at side effects and other drawbacks."

26 Aug 2008